Coba-Males M, Lavecchia M, Alcivar-Leon C, Santamaria-Aguirre J
Molecules. 2023; 28(19).
PMID: 37836772
PMC: 10574177.
DOI: 10.3390/molecules28196929.
Spencer A, Panda S
Biomedicines. 2023; 11(2).
PMID: 36830908
PMC: 9953508.
DOI: 10.3390/biomedicines11020371.
Chattopadhyay G, Ahmed S, Srilatha N, Asok A, Varadarajan R
Protein Sci. 2022; 32(1):e4514.
PMID: 36382921
PMC: 9793979.
DOI: 10.1002/pro.4514.
Fu X, Liu J, Yan X, DiSanto M, Zhang X
Life (Basel). 2022; 12(10).
PMID: 36294924
PMC: 9605364.
DOI: 10.3390/life12101489.
Woziwodzka A, Krychowiak-Masnicka M, Golunski G, Losiewska A, Borowik A, Wyrzykowski D
Pharmaceuticals (Basel). 2022; 15(7).
PMID: 35890171
PMC: 9315996.
DOI: 10.3390/ph15070872.
Inhibitory Compounds Targeting Plasmodium falciparum Gyrase B.
Pakosz Z, Lin T, Michalczyk E, Nagano S, Heddle J
Antimicrob Agents Chemother. 2021; 65(10):e0026721.
PMID: 34339271
PMC: 8448092.
DOI: 10.1128/AAC.00267-21.
The African Swine Fever Virus (ASFV) Topoisomerase II as a Target for Viral Prevention and Control.
Coelho J, Leitao A
Vaccines (Basel). 2020; 8(2).
PMID: 32560397
PMC: 7350233.
DOI: 10.3390/vaccines8020312.
Fluoroquinolones stimulate the DNA cleavage activity of topoisomerase IV by promoting the binding of Mg(2+) to the second metal binding site.
Oppegard L, Schwanz H, Towle T, Kerns R, Hiasa H
Biochim Biophys Acta. 2016; 1860(3):569-75.
PMID: 26723176
PMC: 4720527.
DOI: 10.1016/j.bbagen.2015.12.019.
Targeting Mycobacterium tuberculosis topoisomerase I by small-molecule inhibitors.
Godbole A, Ahmed W, Bhat R, Bradley E, Ekins S, Nagaraja V
Antimicrob Agents Chemother. 2014; 59(3):1549-57.
PMID: 25534741
PMC: 4325804.
DOI: 10.1128/AAC.04516-14.
NBTI 5463 is a novel bacterial type II topoisomerase inhibitor with activity against gram-negative bacteria and in vivo efficacy.
Dougherty T, Nayar A, Newman J, Hopkins S, Stone G, Johnstone M
Antimicrob Agents Chemother. 2014; 58(5):2657-64.
PMID: 24566174
PMC: 3993248.
DOI: 10.1128/AAC.02778-13.
Interfacial inhibitors: targeting macromolecular complexes.
Pommier Y, Marchand C
Nat Rev Drug Discov. 2011; 11(1):25-36.
PMID: 22173432
PMC: 7380715.
DOI: 10.1038/nrd3404.
Exploiting bacterial DNA gyrase as a drug target: current state and perspectives.
Collin F, Karkare S, Maxwell A
Appl Microbiol Biotechnol. 2011; 92(3):479-97.
PMID: 21904817
PMC: 3189412.
DOI: 10.1007/s00253-011-3557-z.
DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.
Pommier Y, Leo E, Zhang H, Marchand C
Chem Biol. 2010; 17(5):421-33.
PMID: 20534341
PMC: 7316379.
DOI: 10.1016/j.chembiol.2010.04.012.
In front of and behind the replication fork: bacterial type IIA topoisomerases.
Sissi C, Palumbo M
Cell Mol Life Sci. 2010; 67(12):2001-24.
PMID: 20165898
PMC: 11115839.
DOI: 10.1007/s00018-010-0299-5.
Mapping simocyclinone D8 interaction with DNA gyrase: evidence for a new binding site on GyrB.
Sissi C, Vazquez E, Chemello A, Mitchenall L, Maxwell A, Palumbo M
Antimicrob Agents Chemother. 2009; 54(1):213-20.
PMID: 19858260
PMC: 2798491.
DOI: 10.1128/AAC.00972-09.
Quinolones: action and resistance updated.
Drlica K, Hiasa H, Kerns R, Malik M, Mustaev A, Zhao X
Curr Top Med Chem. 2009; 9(11):981-98.
PMID: 19747119
PMC: 3182077.
DOI: 10.2174/156802609789630947.
The pentapeptide repeat proteins MfpAMt and QnrB4 exhibit opposite effects on DNA gyrase catalytic reactions and on the ternary gyrase-DNA-quinolone complex.
Merens A, Matrat S, Aubry A, Lascols C, Jarlier V, Soussy C
J Bacteriol. 2008; 191(5):1587-94.
PMID: 19060136
PMC: 2648189.
DOI: 10.1128/JB.01205-08.
Anticoagulant-induced changes on antibiotic concentrations in the serum and bones.
Kotsiou A, Diamanti E, Potamianou A, Parara H, Vovou J, Perisanidis C
Eur J Drug Metab Pharmacokinet. 2008; 33(3):173-9.
PMID: 19007043
DOI: 10.1007/BF03191115.
Quinolone-mediated bacterial death.
Drlica K, Malik M, Kerns R, Zhao X
Antimicrob Agents Chemother. 2007; 52(2):385-92.
PMID: 17724149
PMC: 2224783.
DOI: 10.1128/AAC.01617-06.
The phytotoxin albicidin is a novel inhibitor of DNA gyrase.
Hashimi S, Wall M, Smith A, Maxwell A, Birch R
Antimicrob Agents Chemother. 2006; 51(1):181-7.
PMID: 17074789
PMC: 1797663.
DOI: 10.1128/AAC.00918-06.